Related Experiment Video
Updated: Jul 16, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
Uncovering residues that regulate cyclin D1 proteasomal degradation
1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH 03755, USA.
Abstract:
Cyclin D1 regulates G1 cell-cycle progression and is aberrantly expressed in carcinogenesis. Proteasomal degradation of cyclin D1 was highlighted as a cancer chemopreventive mechanism. To understand this mechanism better, residues responsible for degradation and ubiquitination of cyclin D1 were investigated. Eighteen lysines in cyclin D1 had single, double or multiple mutations engineered before transfection into BEAS-2B human bronchial epithelial (HBE) cells to evaluate stabilities after all-trans-retinoic acid (RA) or cycloheximide treatments. Specific mutations stabilized cyclin D1, including substitutions of lysines surrounding the cyclin box domain that inhibited RA-mediated degradation and extended the cyclin D1 half-life. Mutation of all cyclin D1 lysines blocked polyubiquitination. N-terminus (but not C-terminus) modification stabilized cyclin D1. Ubiquitination-resistant mutants preferentially localized cyclin D1 to the nucleus, directly implicating subcellular localization in regulating cyclin D1 degradation. Taken together, these findings uncover specific residues conferring ubiquitination of cyclin D1. These provide a mechanistic basis for proteasomal degradation of cyclin D1.
Insights
Specific mutations in cyclin D1 (cell cycle regulator) block its proteasomal degradation, revealing key residues involved in ubiquitination and stabilizing the protein. This offers insights into cancer chemoprevention.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cyclin D1 is crucial for cell cycle progression and its abnormal expression is linked to cancer.
- Proteasomal degradation of cyclin D1 is a recognized mechanism for cancer chemoprevention.
Purpose of the Study:
- To identify specific amino acid residues in cyclin D1 responsible for its ubiquitination and proteasomal degradation.
- To elucidate the mechanism by which all-trans-retinoic acid (RA) induces cyclin D1 degradation.
Main Methods:
- Site-directed mutagenesis was used to engineer mutations in eighteen lysine residues of cyclin D1.
- Mutated cyclin D1 was transfected into BEAS-2B human bronchial epithelial cells.
- Cellular stability of mutated cyclin D1 was assessed following treatment with all-trans-retinoic acid (RA) or cycloheximide.
Main Results:
- Specific lysine mutations, particularly those near the cyclin box domain, stabilized cyclin D1 and inhibited RA-mediated degradation.
- Complete mutation of all lysine residues abolished cyclin D1 polyubiquitination.
- N-terminal modifications stabilized cyclin D1, whereas C-terminal modifications did not.
- Ubiquitination-resistant cyclin D1 mutants showed preferential nuclear localization, suggesting a role for subcellular localization in degradation regulation.
Conclusions:
- Specific lysine residues in cyclin D1 are critical for its ubiquitination and subsequent proteasomal degradation.
- These findings provide a mechanistic understanding of cyclin D1 regulation and its role in cancer chemoprevention.
Related Concept Videos
Anaphase Promoting Complex
Inhibition of Cdk Activity
Inhibition of CDK Activity
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Positive Regulator Molecules
Positive Regulator Molecules

